Transaction: PharmEasy has signed a definitive agreement to acquire a majority stake in diagnostics firm Thyrocare Technologies Limited. Thyrocare Technologies Limited has agreed to sell approximately 66.14% of its equity share capital equivalent to 3,49,72,999 equity...
